IIL - Intravenous Infusions Limited
Intravenous Infusions Limited (IIL) is a Ghanaian pharmaceutical company and the market leader in the manufacture of intravenous infusions in the country. IIL was incorporated in 1969 and began operations in 1974 as the first pharmaceutical company producing intravenous infusions in Ghana. The company was set up to take advantage of the total lack of local production of infusions and the country's dependence on imports. Since then, IIL has grown to become the dominating market leader with a market share of about 50% in the country. The company also exports its products to the immediate neighboring countries, namely, Ivory Coast, Burkina Faso, and Togo. Intravenous Infusions Limited listed on the Ghana Alternative Market in December 2015.
|Last Trading Results||Growth & Valuation|
|Opening Price:||--||Earnings Per Share:||0.00|
|Day's Low Price:||--||Price/Earning Ratio:||--|
|Day's High Price:||--||Dividend Per Share:||--|
|Traded Volume:||0||Dividend Yield:||--|
|Number of Deals:||--||Shares Outstanding:||226.64m|
Monetary values are quoted in Ghana Cedis (GHS) unless otherwise stated
IIL Market Performance
IIL currently ranks 13th on the Ghana Stock Exchange in terms of returns to investors with a year-to-date return of zero percent. Following IIL are EGL (-0.42%), CAL (-3.95%), and GGBL (-7.98%). Shareholders are anxiously awaiting when Intravenous Infusions Limited will announce dividends to see whether they have gained something or not. Below is the historical trading trend of IIL, covering up to the last 10 trading sessions of activity.
Profile of Intravenous Infusions Limited
Intravenous Infusions Limited operates in the Health Care sector, specifically, the Pharmaceuticals & Biotechnology industry—according to the reverse Industry Classification Benchmark (ICB) taxonomy. The company's board of directors is composed of eight members whose names are listed below.
- Isaac Osei
- Richard Okrah
- Michael Amafu-Dei
- Kofi Appenteng
- Samuel A. Appenteng
- Leon Appenteng
- Nana Owusu Banahene
- Gladys Amposah
|Factsheet of Intravenous Infusions Limited|
Pharmaceuticals & Biotechnology
Plot 4/7 BIKL, Adjacent Highways workshop, Akwadum Road, Effiduase-Koforidua
Industrial Stock Market Competitors
Intravenous Infusions Limited, issuers of the IIL stock on the Ghana Stock Exchange, have two market competitors who are also engaged in the Health Care/Pharmaceuticals & Biotechnology industry. The table below gives you an overview of their market standing.
|AYRTN||Ayrton Drugs Manufacturing Co. Ltd.||21.50m||0.10||+0.00|
|SPL||Starwin Products Limited||7.79m||0.03||+0.00|